322 related articles for article (PubMed ID: 31862688)
1. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Fallatah W; Smith T; Cui W; Jayasinghe D; Di Pietro E; Ritchie SA; Braverman N
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31862688
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
[TBL] [Abstract][Full Text] [Related]
3. A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.
Braverman N; Zhang R; Chen L; Nimmo G; Scheper S; Tran T; Chaudhury R; Moser A; Steinberg S
Mol Genet Metab; 2010 Apr; 99(4):408-16. PubMed ID: 20060764
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders.
De Biase I; Yuzyuk T; Cui W; Zuromski LM; Moser AB; Braverman NE
Clin Chim Acta; 2023 Mar; 542():117295. PubMed ID: 36914043
[TBL] [Abstract][Full Text] [Related]
5. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.
Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J
Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479
[TBL] [Abstract][Full Text] [Related]
6. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
Wood PL; Smith T; Lane N; Khan MA; Ehrmantraut G; Goodenowe DB
Lipids Health Dis; 2011 Dec; 10():227. PubMed ID: 22142382
[TBL] [Abstract][Full Text] [Related]
7. Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid-deficient mice.
Todt H; Dorninger F; Rothauer PJ; Fischer CM; Schranz M; Bruegger B; Lüchtenborg C; Ebner J; Hilber K; Koenig X; Erdem FA; Gawali VS; Berger J
J Inherit Metab Dis; 2020 Sep; 43(5):1046-1055. PubMed ID: 32441337
[TBL] [Abstract][Full Text] [Related]
8. Growth charts for individuals with rhizomelic chondrodysplasia punctata.
Duker AL; Niiler T; Eldridge G; Brereton NH; Braverman NE; Bober MB
Am J Med Genet A; 2017 Jan; 173(1):108-113. PubMed ID: 27616591
[TBL] [Abstract][Full Text] [Related]
9. Rhizomelic chondrodysplasia punctata and cardiac pathology.
Huffnagel IC; Clur SA; Bams-Mengerink AM; Blom NA; Wanders RJ; Waterham HR; Poll-The BT
J Med Genet; 2013 Jul; 50(7):419-24. PubMed ID: 23572185
[TBL] [Abstract][Full Text] [Related]
10. Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview.
Purdue PE; Skoneczny M; Yang X; Zhang JW; Lazarow PB
Neurochem Res; 1999 Apr; 24(4):581-6. PubMed ID: 10227689
[TBL] [Abstract][Full Text] [Related]
11. Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment.
Malheiro AR; Correia B; Ferreira da Silva T; Bessa-Neto D; Van Veldhoven PP; Brites P
Brain Pathol; 2019 Sep; 29(5):622-639. PubMed ID: 30667116
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
Malheiro AR; da Silva TF; Brites P
J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
[TBL] [Abstract][Full Text] [Related]
13. The importance of ether-phospholipids: a view from the perspective of mouse models.
da Silva TF; Sousa VF; Malheiro AR; Brites P
Biochim Biophys Acta; 2012 Sep; 1822(9):1501-8. PubMed ID: 22659211
[TBL] [Abstract][Full Text] [Related]
14. Functions of plasmalogen lipids in health and disease.
Braverman NE; Moser AB
Biochim Biophys Acta; 2012 Sep; 1822(9):1442-52. PubMed ID: 22627108
[TBL] [Abstract][Full Text] [Related]
15. A
Fallatah W; Cui W; Di Pietro E; Carter GT; Pounder B; Dorninger F; Pifl C; Moser AB; Berger J; Braverman NE
Front Cell Dev Biol; 2022; 10():886316. PubMed ID: 35898397
[TBL] [Abstract][Full Text] [Related]
16. Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.
Noguchi M; Honsho M; Abe Y; Toyama R; Niwa H; Sato Y; Ghaedi K; Rahmanifar A; Shafeghati Y; Fujiki Y
J Hum Genet; 2014 Jul; 59(7):387-92. PubMed ID: 24849933
[TBL] [Abstract][Full Text] [Related]
17. Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.
da Silva TF; Eira J; Lopes AT; Malheiro AR; Sousa V; Luoma A; Avila RL; Wanders RJ; Just WW; Kirschner DA; Sousa MM; Brites P
J Clin Invest; 2014 Jun; 124(6):2560-70. PubMed ID: 24762439
[TBL] [Abstract][Full Text] [Related]
18. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata.
Bams-Mengerink AM; Majoie CB; Duran M; Wanders RJ; Van Hove J; Scheurer CD; Barth PG; Poll-The BT
Neurology; 2006 Mar; 66(6):798-803; discussion 789. PubMed ID: 16567694
[TBL] [Abstract][Full Text] [Related]
19. Expanding the genotypic and phenotypic landscapes of rhizomelic chondrodysplasia punctata type 3 (RCDP3) with two novel families, and a review of the literature.
İli EG; Gezdirici A; Di Pietro E; Yergeau C; Braverman N
Am J Med Genet A; 2022 Nov; 188(11):3229-3235. PubMed ID: 35986576
[TBL] [Abstract][Full Text] [Related]
20. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.
Brites P; Ferreira AS; da Silva TF; Sousa VF; Malheiro AR; Duran M; Waterham HR; Baes M; Wanders RJ
PLoS One; 2011; 6(12):e28539. PubMed ID: 22163031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
